MINERALRITE Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MINERALRITE Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2024 | $5.0K | Mar 25, 2026 |
| FY2013 | Dec 31, 2013 | $397.2K | Aug 12, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2024 | $5.0K | Mar 25, 2026 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2024 | $5.0K | Mar 25, 2026 |
| FY2013 | Dec 31, 2013 | $38.9K | Aug 12, 2014 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($291.5K) | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $396.8K | Mar 25, 2026 |
| FY2013 | Dec 31, 2013 | ($3.53M) | Aug 12, 2014 |
| FY2013 | Dec 31, 2012 | ($454.0K) | Aug 12, 2014 |
| FY2012 | Dec 31, 2011 | ($339.4K) | May 3, 2013 |
| FY2011 | Dec 31, 2010 | ($253.2K) | Apr 16, 2012 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($434.8K) | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | ($366.6K) | Mar 25, 2026 |
| FY2013 | Dec 31, 2013 | ($1.55M) | Aug 12, 2014 |
| FY2013 | Dec 31, 2012 | ($313.0K) | Aug 12, 2014 |
| FY2012 | Dec 31, 2011 | ($292.5K) | May 3, 2013 |
| FY2011 | Dec 31, 2010 | ($212.6K) | Apr 16, 2012 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.1K | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $10.2K | Mar 25, 2026 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($306.4K) | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | ($378.4K) | Mar 25, 2026 |
| FY2013 | Dec 31, 2013 | ($369.3K) | Aug 12, 2014 |
| FY2013 | Dec 31, 2012 | ($11.0K) | Aug 12, 2014 |
| FY2012 | Dec 31, 2011 | ($132.5K) | May 3, 2013 |
| FY2011 | Dec 31, 2010 | ($13.1K) | Apr 16, 2012 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.5K | Mar 25, 2026 |
| FY2013 | Dec 31, 2013 | ($4.3K) | Aug 12, 2014 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $433.83M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $432.26M | Mar 25, 2026 |
| FY2013 | Dec 31, 2013 | $2.23M | Aug 12, 2014 |
| FY2013 | Dec 31, 2012 | $778.4K | Aug 12, 2014 |
| FY2012 | Dec 31, 2011 | $600.9K | May 3, 2013 |
| FY2011 | Dec 31, 2010 | $627.8K | Apr 16, 2012 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.06M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $5.18M | Mar 25, 2026 |
| FY2013 | Dec 31, 2013 | $1.47M | Aug 12, 2014 |
| FY2013 | Dec 31, 2012 | $620.1K | Aug 12, 2014 |
| FY2012 | Dec 31, 2011 | $954.8K | May 3, 2013 |
| FY2011 | Dec 31, 2010 | $857.6K | Apr 16, 2012 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $428.77M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $427.08M | Mar 25, 2026 |
| FY2012 | Dec 31, 2012 | $158.3K | May 3, 2013 |
| FY2012 | Dec 31, 2011 | ($354.0K) | May 3, 2013 |
| FY2011 | Dec 31, 2010 | ($229.8K) | Apr 16, 2012 |
| FY2011 | Dec 31, 2009 | ($346.0K) | Apr 16, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($4.76M) | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | ($4.47M) | Mar 25, 2026 |
| FY2013 | Dec 31, 2013 | ($186) | Aug 12, 2014 |
| FY2013 | Dec 31, 2012 | ($16.1K) | Aug 12, 2014 |
| FY2012 | Dec 31, 2011 | ($5.81M) | May 3, 2013 |
| FY2011 | Dec 31, 2010 | ($5.47M) | Apr 16, 2012 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.6K | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $10.5K | Mar 25, 2026 |
| FY2013 | Dec 31, 2013 | $52.2K | Aug 12, 2014 |
| FY2012 | Dec 31, 2012 | $9.3K | May 3, 2013 |
| FY2013 | Dec 31, 2011 | $33.6K | Aug 12, 2014 |
| FY2012 | Dec 31, 2010 | $205.1K | May 3, 2013 |
| FY2011 | Dec 31, 2009 | $12.0K | Apr 16, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 25, 2026 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 25, 2026 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6.21B | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | 4.35B | Mar 25, 2026 |
| FY2012 | Dec 31, 2012 | 44.56M | May 3, 2013 |
| FY2012 | Dec 31, 2011 | 1.06M | May 3, 2013 |